BEAM
Price
$22.54
Change
+$0.30 (+1.35%)
Updated
May 9, 6:59 PM EST
89 days until earnings call
JANX
Price
$51.94
Change
-$3.43 (-6.19%)
Updated
May 9, 6:59 PM EST
89 days until earnings call
Ad is loading...

BEAM vs JANX

Header iconBEAM vs JANX Comparison
Open Charts BEAM vs JANXBanner chart's image
Beam Therapeutics
Price$22.54
Change+$0.30 (+1.35%)
Volume$519.08K
CapitalizationN/A
Janux Therapeutics
Price$51.94
Change-$3.43 (-6.19%)
Volume$851.12K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs JANX Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JANXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. JANX commentary
May 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and JANX is a Hold.

COMPARISON
Comparison
May 10, 2024
Stock price -- (BEAM: $22.24 vs. JANX: $55.37)
Brand notoriety: BEAM and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 62% vs. JANX: 204%
Market capitalization -- BEAM: $1.86B vs. JANX: $2.87B
BEAM [@Biotechnology] is valued at $1.86B. JANX’s [@Biotechnology] market capitalization is $2.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while JANX’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 3 bearish.
  • JANX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than JANX.

Price Growth

BEAM (@Biotechnology) experienced а +2.30% price change this week, while JANX (@Biotechnology) price change was -4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.21%. For the same industry, the average monthly price growth was -4.72%, and the average quarterly price growth was +71.05%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

JANX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+0.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for JANX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JANX($2.7B) has a higher market cap than BEAM($1.86B). JANX YTD gains are higher at: 416.030 vs. BEAM (-18.295).
BEAMJANXBEAM / JANX
Capitalization1.86B2.7B69%
EBITDAN/AN/A-
Gain YTD-18.295416.030-4%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMJANX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JANXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRUEX16.210.05
+0.31%
MFS Blended Research Value Equity B
PEQLX34.480.03
+0.09%
Putnam Large Cap Value R5
VELIX16.52-0.01
-0.06%
VELA Large Cap Plus I
FFAAX14.93-0.01
-0.07%
Franklin Global Allocation Adv
FMFCX95.71-0.46
-0.48%
Fidelity Advisor Materials C

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VKTX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-9.97%
VKTX - JANX
65%
Loosely correlated
+0.38%
DNLI - JANX
57%
Loosely correlated
+12.17%
LGND - JANX
51%
Loosely correlated
+9.75%
BEAM - JANX
47%
Loosely correlated
-1.29%
NTLA - JANX
42%
Loosely correlated
-3.69%
More